Search | Biogen

Biogen to Present Data from ADUHELM and Alzheimer’s Disease Portfolio at 2021 Alzheimer’s Association International Conference

Q2 2021 Biogen Earnings Presentation

Q2 2021 Biogen Earnings Presentation 3.2 MB

Biogen Reports Second Quarter 2021 Results

Biogen Reports Second Quarter 2021 Results 326.8 KB

An open letter to the Alzheimer’s disease community from our Head of Research and Development, Alfred Sandrock, M.D., Ph.D.

Biogen Reports Second Quarter 2021 Results 326.8 KB

Biogen Reports Second Quarter 2021 Results

Form 8-K

Form 10-Q

Biogen and Innocare Announce License and Collaboration Agreement For Orelabrutinib, an Innovative CNS Penetrant BTK Inhibitor For the Potential Treatment of Multiple Sclerosis

Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease

Biogen to Report Second Quarter 2021 Financial Results July 22, 2021